P. Linson

A prospective study of physical activity and risk of prostate cancer in US physicians.

J. Buring, C. Hennekens, I. Lee, 2000, International journal of epidemiology.

Percentage of core lengths involved with prostate cancer: does it add to the percentage of positive prostate biopsies in predicting postoperative prostate-specific antigen outcome for men with intermediate-risk prostate cancer?

A. D'Amico, J. Richie, Ming-Hui Chen, 2002, Urology.

Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer

A. Kishan, I. Kaplan, R. Meier, 2019, JAMA network open.

Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends

D. Kuban, S. McGuire, K. Hoffman, 2019, Cancer.

Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series

A. Kishan, I. Kaplan, R. Meier, 2021, Advances in radiation oncology.

Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Survival and Toxicity Endpoints.

D. Brachman, I. Kaplan, R. Meier, 2018, International journal of radiation oncology, biology, physics.